# NCT02997228 (NCT02997228)

> Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02997228
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: National Cancer Institute (NCI)
- Conditions: Metastatic Colorectal Adenocarcinoma; Stage IV Colorectal Cancer AJCC v7
- Interventions: Atezolizumab; Bevacizumab; Biospecimen Collection; Computed Tomography; Fluorouracil; Leucovorin; Magnetic Resonance Imaging; Oxaliplatin; Positron Emission Tomography; Quality-of-Life Assessment; Questionnaire Administration
- Enrollment: 120
- Primary outcome: Progression free survival (PFS)

## Indexed commentary on NCT02997228 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct02997228